Industry Experts

An accomplished pharmaceutical researcher with over two decades of experience in comprehensive drug discovery and development. Possessing deep expertise in both small molecules and biologics, with a particular focus on immunology-related therapeutic areas including inflammation, autoimmunity, and immuno-oncology. Has successfully advanced multiple drug candidates to clinical stages, including MHV-370 for autoimmune diseases (in phase 2), SMIP 7.7 for basal cell carcinoma, and a novel anti-CD122 antagonist (phase 1 in 2025). Combines extensive technical knowledge spanning target biology, pharmacology, and pre-clinical validation with a strong foundation in both innate and adaptive immunology. Published research in prestigious journals through academic collaborations, demonstrating a commitment to advancing both fundamental scientific understanding and practical drug development. Currently holding senior management role at NeologicsBio, San Diego, USA.